Showing results (431-440 of 533) with videos related to

Sort By:
Pageof 54
The Journal of Infectious Diseases|September 9, 2015
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesMohammad M Sajadi, Maham Farshidpour, Eric P Brown, et al.
The Journal of Clinical Investigation|August 29, 2024
Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancyAndrew P Hederman, Christopher Al Remmel, Shilpee Sharma, et al.
European Journal of Sport Science|June 15, 2024
Minimal influence of the menstrual cycle or hormonal contraceptives on performance in female rugby league athletesElla S Smith, Jonathon Weakley, Alannah K A McKay, et al.
Mucosal Immunology|February 18, 2016
Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategiesM Sips, M Krykbaeva, T J Diefenbach, et al.
Nature Communications|February 4, 2022
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysisDavid A Spencer, Benjamin S Goldberg, Shilpi Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populationsAndrew P Hederman, Harini Natarajan, Joshua A Wiener, et al.
Retrovirology|October 31, 2021
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody featuresHao D Cheng, Karen G Dowell, Chris Bailey-Kellogg, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2025
Cancer therapy via neoepitope-specific monoclonal antibody cocktailsColin J Hartman, Asmaa O Mohamed, Girja S Shukla, et al.
The Journal of Clinical Investigation|April 9, 2013
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activityMargaret E Ackerman, Max Crispin, Xiaojie Yu, et al.
Open Forum Infectious Diseases|July 16, 2016
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza VaccinePeter F Wright, Anne G Hoen, Natalia A Ilyushina, et al.
Pageof 54